Laparoscopic-Guided Ropivacaine Trocar-Site Infiltration Can Improve Post-Operative Pain Control after Laparoscopic Adrenalectomy.


Journal

Surgical innovation
ISSN: 1553-3514
Titre abrégé: Surg Innov
Pays: United States
ID NLM: 101233809

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 5 12 2021
medline: 18 11 2022
entrez: 4 12 2021
Statut: ppublish

Résumé

There is no consensus on pain control in patients undergoing laparoscopy; nowadays, conventional therapy may be improved by transversus abdominis plane block. The aim of this evaluation is to investigate the role of laparoscopic-assisted trocar-site ropivacaine infiltration during adrenalectomy in pain control. This is a retrospective evaluation of a prospectively maintained database including patients undergoing adrenalectomy. Patients were divided into 2 groups: Group A patients received laparoscopic-assisted trocar-site infiltration of 7.5 mg/mL ropivacaine and Group B patients did not receive any infiltration. All patients received a 24-hour infusion of 20 mg morphine; pain was checked at 6, 24, and 48 hours after surgery by Visual Analogue Scale (VAS) score. A rescue analgesia by was given if VAS score was > 4 or on patient request. No differences in operative time, complications, and post-operative stay and no complications related to trocar-site infiltration were found. 6-hour and 48-hour VAS scores were not found to be significantly different between groups, even if a slight decrease in VAS score in Group A was reported. Group A showed significant reduction in VAS score at 24 hours (2.44 +/- .41 vs 3.01 +/- .78, Laparoscopic-guided trocar-site ropivacaine infiltration can be considered safe and effective in the management of post-operative pain and in the reduction of analgesic need in patients undergoing laparoscopic adrenalectomy. The retrospective nature of the study and the lack of a consistent series of patients require further evaluations.

Sections du résumé

BACKGROUND BACKGROUND
There is no consensus on pain control in patients undergoing laparoscopy; nowadays, conventional therapy may be improved by transversus abdominis plane block. The aim of this evaluation is to investigate the role of laparoscopic-assisted trocar-site ropivacaine infiltration during adrenalectomy in pain control.
METHODS METHODS
This is a retrospective evaluation of a prospectively maintained database including patients undergoing adrenalectomy. Patients were divided into 2 groups: Group A patients received laparoscopic-assisted trocar-site infiltration of 7.5 mg/mL ropivacaine and Group B patients did not receive any infiltration. All patients received a 24-hour infusion of 20 mg morphine; pain was checked at 6, 24, and 48 hours after surgery by Visual Analogue Scale (VAS) score. A rescue analgesia by was given if VAS score was > 4 or on patient request.
RESULTS RESULTS
No differences in operative time, complications, and post-operative stay and no complications related to trocar-site infiltration were found. 6-hour and 48-hour VAS scores were not found to be significantly different between groups, even if a slight decrease in VAS score in Group A was reported. Group A showed significant reduction in VAS score at 24 hours (2.44 +/- .41 vs 3.01 +/- .78,
CONCLUSIONS CONCLUSIONS
Laparoscopic-guided trocar-site ropivacaine infiltration can be considered safe and effective in the management of post-operative pain and in the reduction of analgesic need in patients undergoing laparoscopic adrenalectomy. The retrospective nature of the study and the lack of a consistent series of patients require further evaluations.

Identifiants

pubmed: 34861813
doi: 10.1177/15533506211057967
doi:

Substances chimiques

Ropivacaine 7IO5LYA57N
Anesthetics, Local 0
Analgesics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

747-751

Auteurs

Giuseppe Cavallaro (G)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Andrea Polistena (A)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Luigi Petramala (L)

Department of Translational and Precision Medicine, 9311Sapienza University, Rome, Italy.

Sergio Gazzanelli (S)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Daniele Crocetti (D)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Olga Iorio (O)

General Surgery Unit, F. Spaziani Hospital, Frosinone, Italy.

Angelo Iossa (A)

Department of Medico-Surgical Sciences and Biotechnologies, 9311Sapienza University, Rome, Italy.

Enrico Fiori (E)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Umberto Bracale (U)

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy.

Giorgio De Toma (G)

Department of Surgery "P. Valdoni", 9311Sapienza University, Rome, Italy.

Claudio Letizia (C)

Department of Translational and Precision Medicine, 9311Sapienza University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH